Skip to main content
SpringerLink
Log in
Book cover

The Medical Basis of Psychiatry pp 391–399Cite as

Schizophrenia in Children and Adolescents

  • Chapter

Abstract

This chapter discusses schizophrenia as it occurs in children and adolescents. Because of the complexity of diagnosis of schizophrenia in children and adolescents, this issue is discussed, followed by a discussion of the epidemiology of the illness in this population. Research into the pathophysiology of schizophrenia in youth is reviewed, including studies of genetics, brain imaging, and neuropsychology. Finally, treatment options, including medication and psychosocial interventions, is discussed.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Carlson GA, Strober M. Manic-depressive illness in early adolescence. A study of clinical and diagnostic characteristics in six cases. J Am Acad Child Psychiatry 1978;17:138–153.

    Article  PubMed  CAS  Google Scholar 

  2. Carlson GA, Fennig S, Bromet EJ. The confusion between bipolar disorder and schizophrenia in youth: where does it stand in the 1990s? J Am Acad Child Adolesc Psychiatry 1994;33:453–460.

    Article  PubMed  CAS  Google Scholar 

  3. McKenna K, Gordon CT, Lenane M, Kaysen D, Fahey K, Rapoport JL. Looking for childhood-onset schizophrenia: the first 71 cases screened. J Am Acad Child Adolesc Psychiatry 1994;33:636–644.

    Article  PubMed  CAS  Google Scholar 

  4. McGorry PD, McFarlane C, Patton GC, Bell R, Hibbert ME, Jackson HJ, Bowes G. The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey. Acta Psychiatr Scand 1995;92:241–249.

    Article  PubMed  CAS  Google Scholar 

  5. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 1996;22:353–370.

    PubMed  CAS  Google Scholar 

  6. White T, Ho BC, Ward J, O’Leary D, Andreasen NC. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects. Biol Psychiatry 2006;60:463–471.

    Article  PubMed  Google Scholar 

  7. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J, McFarlane W, Perkins DO, Pearlson GD, Woods SW. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003;29:703–715.

    PubMed  Google Scholar 

  8. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992;20:1–97.

    PubMed  CAS  Google Scholar 

  9. Remschmidt H, Theisen FM. Schizophrenia and related disorders in children and adolescents. J Neural Transm Suppl 2005;69:121–141.

    PubMed  Google Scholar 

  10. Loranger AW. Sex difference in age at onset of schizophrenia. Arch Gen Psychiatry 1984;41:157–161.

    PubMed  CAS  Google Scholar 

  11. Hafner H, Maurer K, Loffler W, Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 1993;162:80–86.

    Article  PubMed  CAS  Google Scholar 

  12. Ropcke B, Eggers C. Early-onset schizophrenia: a 15-year follow-up. Eur Child Adolesc Psychiatry 2005;14:341–350.

    Article  PubMed  Google Scholar 

  13. Gottesman I, McGuffin P, Farmer AE. Clinical Genetics as clues to the “real” genetics of schizophrenia. Schizophr Bull 1987;13(1):23–47.

    PubMed  CAS  Google Scholar 

  14. Heston LL . Psychiatric disorders in foster home reared children of schizophrenic mothers. Br J Psychiatry 1966;112:819–825.

    Google Scholar 

  15. Kety SS, Rosenthal D, Wender PH, Schulsinger F. Mental illness in the biological and adoptive families of adopted schizophrenics. Am J Psychiatry 1971;128:302–306.

    PubMed  CAS  Google Scholar 

  16. Owen MJ, Williams NM, O’Donovan MC. The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry 2004;9:14–27.

    Article  PubMed  CAS  Google Scholar 

  17. Gornick MC, Addington AM, Sporn A, Gogtay N, Greenstein D, Lenane M, Gochman P, Ordonez A, Balkissoon R, Vakkalanka R, Weinberger DR, Rapoport JL, Straub RE Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS). J Autism Dev Disord 2005;35: 831–838.

    Article  PubMed  CAS  Google Scholar 

  18. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982;17:319–334.

    Article  PubMed  Google Scholar 

  19. Keshavan MS, Anderson S, Pettegrew JW. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res 1994;28:239–265.

    Article  PubMed  CAS  Google Scholar 

  20. Lim KO, Ardekani BA, Nierenberg J, Butler PD, Javitt DC, Hoptman MJ. Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia. Am J Psychiatry 2006;163:2008–2010.

    Article  PubMed  Google Scholar 

  21. White T, Kendi AT, Lehericy S, Kendi M, Karatekin C, Guimaraes A, Davenport N, Schulz SC, Lim KO. Disruption of hippocampal connectivity in children and adolescents with schizophrenia—a voxel-based diffusion tensor imaging study. Schizophr Res 2007;90:302–307.

    Article  PubMed  Google Scholar 

  22. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976;2:924–926.

    Article  PubMed  CAS  Google Scholar 

  23. Weinberger DR, DeLisi LE, Perman GP, Targum S, Wyatt RJ. Computed tomography in schizophreniform disorder and other acute psychiatric disorders. Arch Gen Psychiatry 1982;39: 778–783.

    PubMed  CAS  Google Scholar 

  24. Andreasen NC, Flashman L, Flaum M, Arndt S, Swayze V 2nd, O′Leary DS, Ehrhardt JC, Yuh WT. Regional brain abnormalities schizophrenia measured with magnetic resonance imaging. JAMA 1994;272:1763–1769.

    Article  PubMed  CAS  Google Scholar 

  25. Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, Saper CB, Rauch SL. Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 2000;48:99–109.

    Article  PubMed  CAS  Google Scholar 

  26. Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry 1998;55:346–352.

    Article  PubMed  CAS  Google Scholar 

  27. Goff DC, Hennen J, Lyoo IK, Tsai G, Wald LL, Evins AE, Yurgelun-Todd DA, Renshaw PF. Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. Biol Psychiatry 2002;51: 493–497.

    Article  PubMed  CAS  Google Scholar 

  28. Schulz SC, Koller M, Kishore PR, Hamer RM, Friedel RO. Abnormal scans in young schizophrenics. Psychopharmacol Bull 1982;18:163–164.

    Google Scholar 

  29. Schulz SC, Koller MM, Kishore PR, Hamer RM, Gehl JJ, Friedel RO. Ventricular enlargement in teenage patients with schizophrenia spectrum disorder. Am J Psychiatry 1983;140:1592–1595.

    PubMed  CAS  Google Scholar 

  30. Frazier JA, Giedd JN, Hamburger SD, Albus KE, Kaysen D, Vaituzis AC, Rajapakse JC, Lenane MC, McKenna K, Jacobsen LK, Gordon CT, Breier A, Rapoport JL. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Arch Gen Psychiatry 1996;53:617–624.

    PubMed  CAS  Google Scholar 

  31. Friedman L, Findling RL, Kenny JT, Swales TP, Stuve TA, Jesberger JA, Lewin JS, Schulz SC. An MRI study of adolescent patients with either schizophrenia or bipolar disorder as compared to healthy control subjects. Biol Psychiatry 1999;46:78–88.

    Article  PubMed  CAS  Google Scholar 

  32. Schulz SC, Koller MM. Schizophrenia and schizophreniform disorder. In: Hsu LK, Hersen M. eds. Recent Developments in Adolescent Psychiatry. Hoboken, NJ: John Wiley & Sons, 1989:289–308.

    Google Scholar 

  33. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M; HGDH Study Group. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005;62:361–370.

    Article  PubMed  CAS  Google Scholar 

  34. van Haren N, Hulshoff Pol HE, Schnack HG, Cahn W, Mandl RC, Collins DL, Evans AC, Kahn RS. Focal Gray Matter Changes in Schizophrenia across the Course of the Illness: A 5-Year Follow-Up Study. Neuropsychopharmacology 2007;32:2057–2066.

    Article  PubMed  Google Scholar 

  35. Jacobsen LK, Hamburger SD, Van Horn JD, Vaituzis AC, McKenna K, Frazier JA, Gordon CT, Lenane MC, Rapoport JL, Zametkin AJ. Cerebral glucose metabolism in childhood onset schizophrenia. Psychiatry Res 1997;75:131–144.

    Article  PubMed  CAS  Google Scholar 

  36. Kenny JT, Friedman L, Findling RL, Swales TP, Strauss ME, Jesberger JA, Schulz SC. Cognitive impairment in adolescents with schizophrenia. Am J Psychiatry 1997;154: 1613–1615.

    PubMed  CAS  Google Scholar 

  37. Wozniak J, White TJ, Blick EE, Schulz SC. Neurocognitive Functioning and Clinical Status During the First Year of Treatment in Adolescent-Onset Psychosis, Winter Workshop on Schizophrenia Research, 2006; Vol 81. Davos, Switzerland: Schizophrenia Research, pp 132.

    Google Scholar 

  38. Hoff AL, Sakuma M, Wieneke M, Horon R, Kushner M, DeLisi LE. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am J Psychiatry 1999;156:1336–1341.

    PubMed  CAS  Google Scholar 

  39. Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996;153: 321–330.

    PubMed  CAS  Google Scholar 

  40. Cole JO, Goldberg SC, Klerman GL. Phenothiazine treatment in acute schizophrenia. Arch Gen Psychiatry 1964;10:246–261.

    Google Scholar 

  41. Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 2003;60:553–564.

    Article  PubMed  CAS  Google Scholar 

  42. Davis JM, Schaffer CB, Killian GA, Kinard C, Chan C. Important issues in the drug treatment of schizophrenia. Schizophr Bull 1980;6:70–87.

    PubMed  CAS  Google Scholar 

  43. Falloon IR, Boyd JL, McGill CW, Razani J, Moss HB, Gilderman AM. Family management in the prevention of exacerbations of schizophrenia: a controlled study. N Engl J Med 1982;306:1437–1440.

    PubMed  CAS  Google Scholar 

  44. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005;162:1785–1804.

    Article  PubMed  Google Scholar 

  45. Keefe RS, Young CA, Rock SL, Purdon SE, Gold JM, Breier A. One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia. Schizophr Res 2006;81:1–15.

    Google Scholar 

  46. Velligan DI, Prihoda TJ, Sui D, Ritch JL, Maples N, Miller AL. The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings. J Clin Psychiatry 2003;64: 524–531.

    Article  PubMed  CAS  Google Scholar 

  47. Realmuto GM, Erickson WD, Yellin AM, Hopwood JH, Greenberg LM. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents. Am J Psychiatry 1984;141:440–442.

    PubMed  CAS  Google Scholar 

  48. Spencer EK, Kafantaris V, Padron-Gayol MV, Rosenberg CR, Campbell M. Haloperidol in schizophrenic children: early findings from a study in progress. Psychopharmacol Bull 1992;28:183–186.

    PubMed  CAS  Google Scholar 

  49. Armenteros JL, Whitaker AH, Welikson M, Stedge DJ, Gorman J. Risperidone in adolescents with schizophrenia: an open pilot study. J Am Acad Child Adolesc Psychiatry 1997;36:694–700.

    Article  PubMed  CAS  Google Scholar 

  50. Grcevich SJ, Findling RL, Rowane WA, Friedman L, Schulz SC. Risperidone in the treatment of children and adolescents with schizophrenia: a retrospective study. J Child Adolesc Psychopharmacol 1996;6:251–257.

    PubMed  CAS  Google Scholar 

  51. Quintana H, Keshavan M. Risperidone in children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 1995;34:1292–1296.

    Article  PubMed  CAS  Google Scholar 

  52. Zalsman G, Carmon E, Martin A, Bensason D, Weizman A, Tyano S. Effectiveness, safety, and tolerability of risperidone in adolescents with schizophrenia: an open-label study. J Child Adolesc Psychopharmacol 2003;13:319–327.

    Article  PubMed  Google Scholar 

  53. Dickson RA, Dalby JT, Williams R, Edwards AL. Risperidone-induced prolactin elevations in premenopausal women with schizophrenia. Am J Psychiatry 1995;152:1102–1103.

    PubMed  CAS  Google Scholar 

  54. Findling RL, McNamara NK, Youngstrom EA, Branicky LA, Demeter CA, Schulz SC. A prospective, open-label trial of olanzapine in adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 2003;42:170–175.

    Article  PubMed  Google Scholar 

  55. Kryzhanovskaya L, Schulz C, McDougle CJ, Frazier JA, Dittmann R, Robertson-Plouch C, Bauer T, Xu W, Wang WV, Carlson J, Tohen M. Olanzapine treatment in male and female adolescent and young adult patients with schizophrenia. Winter Workshop on Schizophrenia Research 2006; Vol 81. Davos, Switzerland: Schizophr Res, pp 44–45.

    Google Scholar 

  56. Kryzhanovskaya L, Carlson G, DelBello M, Findling R, Kowatch R, Schulz SC, Robertson-Plouch C, Xu W, Carlson J, Tohen M. Changes in metabolic parameters in adolescents with schizophrenia or bipolar disorder during treatment with olanzapine: A pooled analysis of 4 studies. International Congress on Schizophrenia Research, 2007; Vol 33. Colorado Springs: Schizophr Bull, pp 501.

    Google Scholar 

  57. McConville BJ, Arvanitis LA, Thyrum PT, Yeh C, Wilkinson LA, Chaney RO, Foster KD, Sorter MT, Friedman LM, Brown KL, Heubi JE. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders. J Clin Psychiatry 2000;61:252–260.

    PubMed  CAS  Google Scholar 

  58. McConville B, Carrero L, Sweitzer D, Potter L, Chaney R, Foster K, Sorter M, Friedman L, Browne K. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial. J Child Adolesc Psychopharmacol 2003;13:75–82.

    Article  PubMed  Google Scholar 

  59. Shaw JA, Lewis JE, Pascal S, Sharma RK, Rodriguez RA, Guillen R, Pupo-Guillen M. A study of quetiapine: efficacy and tolerability in psychotic adolescents. J Child Adolesc Psychopharmacol 2001;11:415–424.

    Article  PubMed  CAS  Google Scholar 

  60. Jensen JB, Leitten W, Wozniak J, Anjum A, White T, Oberstar J, Block E, Guimares A, Lee S, Schulz SC.Efficacy and tolerability of atypical antipsychotics in adolescents with psychosis. International Congress on Schizophrenia Research, 2007; Vol 33. Colorado Springs, CO: Schizopr Bull, pp 500.

    Google Scholar 

  61. Sikich L, Hamer RM, Bashford RA, Sheitman BB, Lieberman JA. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial. Neuropsychopharmacology 2004;29:133–145.

    Article  PubMed  CAS  Google Scholar 

  62. Sikich L. Individual Psychotherapy and School Interventions for Psychotic Youth. In: Findling RL, Schulz SC, eds. Juvenile-Onset Schizophrenia. Baltimore, MD: The Johns Hopkins University Press: 257–287.

    Google Scholar 

  63. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789–796.

    Google Scholar 

  64. Kumra S, Frazier JA, Jacobsen LK, McKenna K, Gordon CT, Lenane MC, Hamburger SD, Smith AK, Albus KE, Alaghband-Rad J, Rapoport JL. Childhood-onset schizophrenia. A double-blind clozapine-haloperidol comparison. Arch Gen Psychiatry 1996;53:1090–1097.

    PubMed  CAS  Google Scholar 

  65. Remschmidt H, Schulz E, Martin PDM. An open trial of clozapine in thirty-six adolescents with schizophrenia. J Child Adolesc Psychopharmacol 1994;5:31–41.

    Google Scholar 

  66. Remschmidt H, Fleischhaker C, Hennighausen K, Schulz E. Management of schizophrenia in children and adolescents. The role of clozapine. Paediatr Drugs 2000;2:253–262.

    Article  PubMed  CAS  Google Scholar 

  67. Zipursky R, Schulz SC. The Early Stages of Schizophrenia. Washington, DC: American Psychiatric Publishing, Inc., 2002.

    Google Scholar 

Download references

Authors
  1. S. Charles Schulz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth deOreo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Psychiatry, University of Minnesota Medical School Medicine, 420 Delaware Street, SE Minneapolis, MN 55455, USA

    S. Hossein Fatemi PhD

  2. American Foundation for Suicide Prevention, 120 Wall Street, New York, NY 10005, USA

    Paula J. Clayton MD (Medical Director) (Medical Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Schulz, S.C., deOreo, E. (2008). Schizophrenia in Children and Adolescents. In: Fatemi, S.H., Clayton, P.J. (eds) The Medical Basis of Psychiatry. Humana Press. https://doi.org/10.1007/978-1-59745-252-6_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-252-6_22

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-917-8

  • Online ISBN: 978-1-59745-252-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation